Read more about our research within Pharmaceutical microbiology and immunity at our research group web sites:
Bacterial Evolution and Disease (BadBugs) - Økstad group
Microbial pathogenesis, vaccines and antimicrobial resistance (MicroPath) - Winther-Larsen group
Virus and vaccines - Gjøen group
The research group contributes towards the United Nations (UN) sustainability developmental goals.
About the Laboratory
Pharmaceutical microbiology and immunity was initiated under the name Laboratory for Microbial Dynamics (LaMDa) as an emerging top-tier research laboratory at the Faculty of Mathematics and Natural Sciences (MN faculty) in 2008, and was later granted the strategic MN faculty initiative CIME (Center for Integrative Microbiology and Evolution, now discontinued). The laboratory is closely associated with several other research groups working within molecular microbiology at the MN Faculty, as well as at other UiO Faculties (Medicine, Odontology), and with other Norwegian and international collaborators. The research is centered around several topics within microbial research.
The laboratory currently receives research funding through the Research Council of Norway, the Norwegian Cancer Society, EU, and internal grants from the University of Oslo (from The Faculty of Mathematics and Natural Sciences, the Department of Pharmacy and University of Oslo Life Sciences).
Our goal is threefold:
1) To perform first class science
2) To create an environment where younger students and scientists can learn and develop into more mature scientists
3) Explore the possibilities of translating our research into new products for the benefit of society
Research group leaders
Pharmaceutical microbiology and immunity is hosted by four principal investigators (PI) with permanent affiliation to the Department of Pharmacy:
Professor Ole Andreas Løchen Økstad
Professor Hanne Cecilie Winther-Larsen
Professor Trine Ballestad Rounge
